For: | Kim YJ, Lee ES, Kim SH, Lee HY, Noh SM, Kang DY, Lee BS. Inhibitory effects of rapamycin on the different stages of hepatic fibrosis. World J Gastroenterol 2014; 20(23): 7452-7460 [PMID: 24966615 DOI: 10.3748/wjg.v20.i23.7452] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v20/i23/7452.htm |
Number | Citing Articles |
1 |
Sushila Maharjan, Diana Bonilla, Princy Sindurakar, Hongbin Li, Wanlu Li, Sergio Duarte, Ali Zarrinpar, Y. Shrike Zhang. 3D human nonalcoholic hepatic steatosis and fibrosis models. Bio-Design and Manufacturing 2021; 4(2): 157 doi: 10.1007/s42242-020-00121-4
|
2 |
Seyed Soheil Saeedi Saravi, Mahmoud Ghazi-Khansari, Shahram Ejtemaei Mehr, Maliheh Nobakht, Seyyedeh Elaheh Mousavi, Ahmad Reza Dehpour. Contribution of mammalian target of rapamycin in the pathophysiology of cirrhotic cardiomyopathy. World Journal of Gastroenterology 2016; 22(19): 4685-4694 doi: 10.3748/wjg.v22.i19.4685
|
3 |
Cindy X. Cai, Hema Buddha, Shobha Castelino-Prabhu, Zhiwei Zhang, Robert S. Britton, Bruce R. Bacon, Brent A. Neuschwander-Tetri. Activation of Insulin-PI3K/Akt-p70S6K Pathway in Hepatic Stellate Cells Contributes to Fibrosis in Nonalcoholic Steatohepatitis. Digestive Diseases and Sciences 2017; 62(4): 968 doi: 10.1007/s10620-017-4470-9
|
4 |
Omnia S. Erfan, Hany M. A. Sonpol, Marwa Abd El‐kader. Protective effect of rapamycin against acrylamide‐induced hepatotoxicity: The associations between autophagy, apoptosis, and necroptosis. The Anatomical Record 2021; 304(9): 1984 doi: 10.1002/ar.24587
|
5 |
Lanlan Shan, Yan Ding, You Fu, Ling Zhou, Xiaoying Dong, Shunzhi Chen, Hongyuan Wu, Wenqing Nai, Hang Zheng, Wanfu Xu, Xiaochun Bai, Chunhong Jia, Meng Dai. mTOR Overactivation in Mesenchymal cells Aggravates CCl4− Induced liver Fibrosis. Scientific Reports 2016; 6(1) doi: 10.1038/srep36037
|
6 |
Paolo Fagone, Katia Mangano, Antonio Pesce, Teresa Rosanna Portale, Stefano Puleo, Ferdinando Nicoletti. Emerging therapeutic targets for the treatment of hepatic fibrosis. Drug Discovery Today 2016; 21(2): 369 doi: 10.1016/j.drudis.2015.10.015
|
7 |
Wanangkan Poolsri, Rattikarn Noitem, Promsuk Jutabha, Manasanan Raveesunthornkiat, Ade Danova, Warinthorn Chavasiri, Chatchai Muanprasat. Discovery of a chalcone derivative as an anti-fibrotic agent targeting transforming growth factor-β1 signaling: Potential therapy of renal fibrosis. Biomedicine & Pharmacotherapy 2023; 165: 115098 doi: 10.1016/j.biopha.2023.115098
|
8 |
Yanling Zhao, Xiao Ma, Jiabo Wang, Xuan He, Yan Hu, Ping Zhang, Ruilin Wang, Ruisheng Li, Man Gong, Shengqiang Luo, Xiaohe Xiao. Curcumin Protects against CCl4-Induced Liver Fibrosis in Rats by Inhibiting HIF-1α Through an ERK-Dependent Pathway. Molecules 2014; 19(11): 18767 doi: 10.3390/molecules191118767
|
9 |
Shuai Zhao, Yu Sun, Xiaolei Li, Jingcheng Wang, Lianqi Yan, Hui Chen, Daxin Wang, Jihang Dai, Jun He. Reduction of intraarticular adhesion of knee by local application of rapamycin in rabbits via inhibition of fibroblast proliferation and collagen synthesis. Journal of Orthopaedic Surgery and Research 2016; 11(1) doi: 10.1186/s13018-016-0375-0
|
10 |
Aleksandra Wilk, Dagmara Szypulska-Koziarska, Karolina Kędzierska-Kapuza, Agnieszka Kolasa-Wołosiuk, Kamila Misiakiewicz-Has, Kazimierz Ciechanowski, Barbara Wiszniewska. Effect of long-term immunosuppressive therapy on native rat liver morphology and hepatocyte- apoptosis. Transplant Immunology 2018; 50: 1 doi: 10.1016/j.trim.2018.05.001
|
11 |
Valeria Mariotti, Romina Fiorotto, Massimiliano Cadamuro, Luca Fabris, Mario Strazzabosco. New insights on the role of vascular endothelial growth factor in biliary pathophysiology. JHEP Reports 2021; 3(3): 100251 doi: 10.1016/j.jhepr.2021.100251
|
12 |
Kriti Tyagi, Ramgopal Prajapati. Medicinal Biotechnology. 2025; : 143 doi: 10.1016/B978-0-443-22264-1.00008-6
|
13 |
Yanling Zhao, Xiao Ma, Jiabo Wang, Yun Zhu, Ruisheng Li, Jian Wang, Xuan He, Limei Shan, Ruilin Wang, Lifu Wang, Yonggang Li, Xiaohe Xiao. Paeoniflorin alleviates liver fibrosis by inhibiting HIF-1α through mTOR-dependent pathway. Fitoterapia 2014; 99: 318 doi: 10.1016/j.fitote.2014.10.009
|
14 |
Kuo-Cheng Wu, Hui-Chun Huang, Ting Chang, Wen-Shin Lee, Chiao-Lin Chuang, I-Fang Hsin, Shao-Jung Hsu, Fa-Yauh Lee, Ching-Chih Chang, Shou-Dong Lee. Effect of sirolimus on liver cirrhosis and hepatic encephalopathy of common bile duct-ligated rats. European Journal of Pharmacology 2018; 824: 133 doi: 10.1016/j.ejphar.2018.02.016
|
15 |
Nutan Sharma, Lakhwinder Singh, Aditya Sharma, Ajay Kumar, Dinesh Mahajan. NAFLD-associated hepatocellular carcinoma (HCC) – A compelling case for repositioning of existing mTORc1 inhibitors. Pharmacological Research 2024; 208: 107375 doi: 10.1016/j.phrs.2024.107375
|